-4%

CJC & Ipa( CJC-1295 No DAC )

Name: CJC &amp; Ipa( CJC-1295 No DAC )
SKU: 539
Availability: InStock

Price range: $55.30 through $75.30

CJC-1295 No DAC (5mg) and Ipamorelin (5mg)

This peptide blend combines CJC-1295 No DAC (5mg) and Ipamorelin (5mg) in a convenient formulation designed exclusively for scientific research purposes. Researchers exploring peptide interactions and biochemical pathways may find this blend beneficial for their studies. Each vial is carefully synthesized and tested to ensure high purity and quality. This product is intended for laboratory research and analysis only and is not for human use. For detailed handling and storage guidelines, refer to the included specifications.

QTY

Clear

SKU: N/A Category: Skin & Hair

CJC-1295 No DAC (5mg) and Ipamorelin (5mg)

Key Details

Property	Details
Chemical Formula	C203H320N56O51
Molecular Mass	4359.14 g/mol
CAS Number	863288-34-0 & 170851-70-4
Vial Size	3 ml
Vial Contents	Lyophilized Powder
Blend Components	CJC-1295 No DAC 5mg, Ipamorelin 5mg

Details

Intended Use: This peptide blend of CJC-1295 No DAC and Ipamorelin is designed for research purposes only and comes in lyophilized form and must be reconstituted.

Storage: Store the vial in a cool, dry place away from direct sunlight. Once reconstituted, keep refrigerated at 2-8°C.

Solubility: Reconstitute with bacteriostatic water for optimal results.

Shelf Life: The lyophilized form has a shelf life of 24 months when stored properly. After reconstitution, refrigerate and use within 4-6 weeks.

Handling: Maintain sterile techniques to preserve the product’s integrity during research applications.

Research Section: Studies on CJC-1295 No DAC and Ipamorelin Blend

Research into the combined use of CJC-1295 No DAC and Ipamorelin has explored their potential synergistic effects on growth hormone (GH) secretion. While direct studies on this specific combination are limited, findings from individual research on each peptide provide valuable insights into their potential combined outcomes.

CJC-1295 No DAC Research

Growth Hormone Release:
Studies have demonstrated that CJC-1295 can significantly enhance GH levels. For example, a single administration of CJC-1295 in animal models resulted in elevated GH levels lasting up to six days.
Insulin-Like Growth Factor 1 (IGF-1) Levels:
Research indicates that CJC-1295 administration leads to a sustained increase in IGF-1 levels, with reports of a 44% increase following a single injection.

Ipamorelin Research

Growth Hormone Secretion:
Ipamorelin has been observed to stimulate GH release in a pulsatile manner, producing short-term GH spikes. It selectively targets GH pathways, minimizing effects on other hormones.
Bone Growth:
Research suggests that Ipamorelin promotes bone growth by stimulating both mineralization of existing bone and deposition of new bone tissue.

Combined Use of CJC-1295 No DAC and Ipamorelin

Synergistic Effects:
Combining a growth hormone-releasing peptide (GHRP) like Ipamorelin with a growth hormone-releasing hormone (GHRH) analog like CJC-1295 creates a synergistic effect on GH secretion. Ipamorelin’s short-term GH pulses, paired with CJC-1295’s prolonged action, lead to enhanced GH levels throughout the day.
Research Applications:
This combination allows researchers to explore how sustained GH stimulation impacts physiological processes such as muscle growth, fat metabolism, and aging mechanisms. The synergy provides a broader perspective on the role of GH in various experimental settings.

Key Findings

CJC-1295 can sustain elevated GH levels for up to six days.
Ipamorelin provides selective, pulsatile GH release with minimal side effects.
Combined use enhances total GH secretion over time, creating a unique model for understanding GH interactions in research contexts.

Disclaimer:
The information above is based on research conducted on animal models or in vitro experiments and is intended for educational purposes only. This peptide blend is for research use only and not intended for human use.

Mechanism of Action

The CJC-1295 No DAC and Ipamorelin blend operates through complementary mechanisms that amplify growth hormone (GH) secretion by targeting different points in the GH regulatory pathway. Their combined action enhances research opportunities to study GH dynamics in various contexts.

CJC-1295 No DAC: Mechanism of Action

CJC-1295 No DAC is a growth hormone-releasing hormone (GHRH) analog, designed to mimic the action of naturally occurring GHRH. It works by binding to the GHRH receptors located on the anterior pituitary gland.

Stimulation of GH Release:
IGF-1 Stimulation:
Prolonged Activity Without DAC:

Ipamorelin: Mechanism of Action

Ipamorelin is a selective growth hormone secretagogue (GHS) and a ghrelin receptor agonist. It acts differently from GHRH analogs, targeting receptors that mimic the action of the hormone ghrelin.

Stimulation of GH Secretion:
Endogenous Ghrelin Mimicry:

Synergistic Mechanism of the Blend

When used together, CJC-1295 No DAC and Ipamorelin create a synergistic effect on GH secretion due to their complementary actions:

CJC-1295 No DAC: Provides sustained baseline elevation of GH levels by stimulating the pituitary over an extended period.
Ipamorelin: Enhances short-term GH spikes, complementing CJC-1295’s prolonged activity to create a more dynamic GH profile.

The result is a consistent baseline of elevated GH levels with intermittent spikes, closely mimicking natural GH secretion patterns in vivo. This synergy makes the blend a valuable tool for researchers studying: